array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Regeneron Pharmaceuticals Inc" ["slug"]=> string(38) "c469a-us-regeneron-pharmaceuticals-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77" ["description"]=> string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. " ["address_street"]=> string(25) "777 Old Saw Mill River Rd" ["address_place"]=> string(9) "Tarrytown" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1988-02-08" ["website_domain"]=> string(13) "regeneron.com" ["website_url"]=> string(25) "https://www.regeneron.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(10368) ["article_count"]=> int(2748) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(171) "NASDAQ: REGN Lawsuit Against Directors Pending - Investors Who Hold Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Long Should Contact the Shareholders Foundation" ["snippet_en"]=> string(149) "The Shareholders Foundation, Inc. announces that a lawsuit is currently pending by an investor in NASDAQ:REGN shares against certain directors of ..." ["url"]=> string(103) "https://www.newswire.com/news/nasdaq-regn-lawsuit-against-directors-pending-investors-who-hold-22423285" ["image_url"]=> NULL ["source"]=> string(12) "newswire.com" ["publication_date"]=> string(10) "2024-09-11" ["categories"]=> array(12) { [0]=> string(16) "Share Repurchase" [1]=> string(10) "Litigation" [2]=> string(5) "Legal" [3]=> string(24) "Stock Research & Ratings" [4]=> string(21) "Shareholders Feedback" [5]=> string(14) "Issuing Shares" [6]=> string(12) "Stock Market" [7]=> string(18) "General Investment" [8]=> string(9) "Investors" [9]=> string(46) "Management of Legal and Regulatory Environment" [10]=> string(20) "Corporate Governance" [11]=> string(18) "Board Compensation" } } [1]=> array(7) { ["title_en"]=> string(62) "Regeneron Says Congress Wanted Tougher Kickback Claim Standard" ["snippet_en"]=> string(168) "Regeneron Pharmaceuticals Inc. urged an appeals court to impose a higher causation standard in the government’s False Claims Act case alleging a drug kickback scheme." ["url"]=> string(103) "https://news.bloomberglaw.com/litigation/regeneron-says-congress-wanted-tougher-kickback-claim-standard" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0f53c752-7309-496b-af7d-7d4e1469218b" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2024-05-17" ["categories"]=> array(2) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(5) "Legal" } } [2]=> array(7) { ["title_en"]=> string(71) "US appeals court revives Regeneron's antitrust lawsuit against Novartis" ["snippet_en"]=> string(258) "NEW YORK (Reuters) -A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron Pharmaceuticals against Novartis related to prescription treatments to address a condition that can lead to eye disorders including permanent blindness. The 2nd U.S." ["url"]=> string(76) "https://ca.news.yahoo.com/us-appeals-court-revives-regenerons-141546622.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0ca9dd7e-b0ed-441e-96e8-bb1697c60801" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-03-18" ["categories"]=> array(7) { [0]=> string(21) "Competitive Behaviour" [1]=> string(10) "Litigation" [2]=> string(5) "Legal" [3]=> string(9) "Antitrust" [4]=> string(8) "Verdicts" [5]=> string(46) "Management of Legal and Regulatory Environment" [6]=> string(14) "Product Launch" } } [3]=> array(7) { ["title_en"]=> string(59) "Greenburgh Sues to Block Edgemont Incorporation Legislation" ["snippet_en"]=> string(300) "By Rick Pezzullo— The Greenburgh Town Board has taken legal action again to try to prevent Edgemont from becoming the town’s seventh incorporated village. During a special meeting Jan. 12, the board adopted a resolution hiring former state Supreme Court Justice Peter Sherwood to oppose a pending" ["url"]=> string(93) "https://thehudsonindependent.com/greenburgh-sues-to-block-edgemont-incorporation-legislation/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1ccb29a3-a184-41d5-b52d-53dbc628a772" ["source"]=> string(24) "thehudsonindependent.com" ["publication_date"]=> string(10) "2024-01-23" ["categories"]=> array(4) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(5) "Legal" [2]=> string(20) "Corporate Governance" [3]=> string(11) "Legislation" } } [4]=> array(7) { ["title_en"]=> string(10) "Healthcare" ["snippet_en"]=> string(52) "Shares of the biotech firm show risks of downdrafts." ["url"]=> string(104) "https://realmoney.thestreet.com/healthcare/regeneron-is-pointed-higher-with-risks-of-downdrafts-16137157" ["image_url"]=> string(78) "https://images.businessradar.com/articles/fc69edc2-eab3-4161-843b-46b6dfcc73d8" ["source"]=> string(13) "thestreet.com" ["publication_date"]=> string(10) "2023-11-03" ["categories"]=> array(4) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(24) "Stock Research & Ratings" [2]=> string(11) "Acquisition" [3]=> string(12) "Stock Market" } } [5]=> array(7) { ["title_en"]=> string(64) "Regeneron Gets Judge to Certify Charity Kickback Suit for Appeal" ["snippet_en"]=> string(196) "Regeneron Pharmaceuticals Inc. showed that an appeals court needs to address how closely connected a kickback must be to an allegedly false claim before the a suit against it can proceed to trial." ["url"]=> string(114) "https://news.bloomberglaw.com/federal-contracting/regeneron-gets-judge-to-certify-charity-kickback-suit-for-appeal" ["image_url"]=> string(78) "https://images.businessradar.com/articles/fe557120-750c-45b0-ba4e-e442682cf4fa" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2023-10-26" ["categories"]=> array(4) { [0]=> string(10) "Litigation" [1]=> string(5) "Legal" [2]=> string(46) "Management of Legal and Regulatory Environment" [3]=> string(8) "Verdicts" } } [6]=> array(7) { ["title_en"]=> string(77) "SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOVO, DBTX, DM, ZYNE" ["snippet_en"]=> string(300) "NEW YORK, Sept. 07, 2023( GLOBE NEWSWIRE)— Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Sovos Brands, Inc.( NASDAQ: SOVO)’ s sale to" ["url"]=> string(103) "https://forextv.com/top-news/shareholder-investigation-halper-sadeh-llc-investigates-sovo-dbtx-dm-zyne/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/db11ab02-5ea4-418d-839a-73801d6d09ed" ["source"]=> string(11) "forextv.com" ["publication_date"]=> string(10) "2023-09-07" ["categories"]=> array(4) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(10) "Divestment" [2]=> string(22) "Shareholder Reputation" [3]=> string(5) "Legal" } } [7]=> array(7) { ["title_en"]=> string(79) "SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRTV, DBTX, CPRI, AVID" ["snippet_en"]=> string(301) "NEW YORK, Aug. 23, 2023( GLOBE NEWSWIRE)— Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Veritiv Corporation( NYSE: VRTV)’ s sale to an" ["url"]=> string(105) "https://forextv.com/top-news/shareholder-investigation-halper-sadeh-llc-investigates-vrtv-dbtx-cpri-avid/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a618de2a-edb7-4976-936c-dd6b00add97a" ["source"]=> string(11) "forextv.com" ["publication_date"]=> string(10) "2023-08-23" ["categories"]=> array(5) { [0]=> string(22) "Shareholder Reputation" [1]=> string(5) "Legal" [2]=> string(21) "Shareholders Feedback" [3]=> string(10) "Divestment" [4]=> string(46) "Management of Legal and Regulatory Environment" } } [8]=> array(7) { ["title_en"]=> string(200) "DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX" ["snippet_en"]=> string(149) "Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed" ["url"]=> string(253) "https://www.businesswire.com/news/home/20230812576390/en/DECIBEL-THERAPEUTICS-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Decibel-Therapeutics-Inc.---DBTX/" ["image_url"]=> NULL ["source"]=> string(16) "businesswire.com" ["publication_date"]=> string(10) "2023-08-12" ["categories"]=> array(2) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(5) "Legal" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(263) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(201) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(196) } [3]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(129) } [4]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(116) } [5]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(116) } [6]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(93) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(79) } [8]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(67) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(66) } [10]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(61) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(59) } [12]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(57) } [13]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(56) } [14]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(53) } [15]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(43) } [16]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(40) } [17]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(38) } [18]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(37) } [19]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(37) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(37) } [21]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(35) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(33) } [23]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(32) } [24]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(31) } [25]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(28) } [26]=> array(2) { ["name"]=> string(14) "Product Review" ["count"]=> int(28) } [27]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(25) } [28]=> array(2) { ["name"]=> string(11) "Sponsorship" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(21) "Intellectual Property" ["count"]=> int(20) } } } c469a-us-regeneron-pharmaceuticals-inc